226 related articles for article (PubMed ID: 20001314)
1. Mode of coreceptor use by R5 HIV type 1 correlates with disease stage: a study of paired plasma and cerebrospinal fluid isolates.
Karlsson U; Antonsson L; Repits J; Medstrand P; Owman C; Kidd-Ljunggren K; Hagberg L; Svennerholm B; Jansson M; Gisslén M; Ljungberg B
AIDS Res Hum Retroviruses; 2009 Dec; 25(12):1297-1305. PubMed ID: 20001314
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 escape to CCR5 coreceptor antagonism through selection of CXCR4-using variants in vitro.
Moncunill G; Armand-Ugón M; Pauls E; Clotet B; Esté JA
AIDS; 2008 Jan; 22(1):23-31. PubMed ID: 18090388
[TBL] [Abstract][Full Text] [Related]
3. A small-molecule, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity.
Baba M; Nishimura O; Kanzaki N; Okamoto M; Sawada H; Iizawa Y; Shiraishi M; Aramaki Y; Okonogi K; Ogawa Y; Meguro K; Fujino M
Proc Natl Acad Sci U S A; 1999 May; 96(10):5698-703. PubMed ID: 10318947
[TBL] [Abstract][Full Text] [Related]
4. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 chemokine coreceptor utilization in paired cerebrospinal fluid and plasma samples: a survey of subjects with viremia.
Spudich SS; Huang W; Nilsson AC; Petropoulos CJ; Liegler TJ; Whitcomb JM; Price RW
J Infect Dis; 2005 Mar; 191(6):890-8. PubMed ID: 15717264
[TBL] [Abstract][Full Text] [Related]
6. HIV type 1 chemokine coreceptor use among antiretroviral-experienced patients screened for a clinical trial of a CCR5 inhibitor: AIDS Clinical Trial Group A5211.
Wilkin TJ; Su Z; Kuritzkes DR; Hughes M; Flexner C; Gross R; Coakley E; Greaves W; Godfrey C; Skolnik PR; Timpone J; Rodriguez B; Gulick RM
Clin Infect Dis; 2007 Feb; 44(4):591-5. PubMed ID: 17243065
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands.
Ghezzi S; Menzo S; Brambilla A; Bordignon PP; Lorini AL; Clementi M; Poli G; Vicenzi E
Virology; 2001 Feb; 280(2):253-61. PubMed ID: 11162839
[TBL] [Abstract][Full Text] [Related]
8. HIV coreceptor tropism in paired plasma, peripheral blood mononuclear cell, and cerebrospinal fluid isolates from antiretroviral-naïve subjects.
Parisi SG; Andreoni C; Sarmati L; Boldrin C; Buonomini AR; Andreis S; Scaggiante R; Cruciani M; Bosco O; Manfrin V; d'Ettorre G; Mengoli C; Vullo V; Palù G; Andreoni M
J Clin Microbiol; 2011 Apr; 49(4):1441-5. PubMed ID: 21367995
[TBL] [Abstract][Full Text] [Related]
9. Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype.
Karlsson I; Antonsson L; Shi Y; Oberg M; Karlsson A; Albert J; Olde B; Owman C; Jansson M; Fenyö EM
J Virol; 2004 Nov; 78(21):11807-15. PubMed ID: 15479822
[TBL] [Abstract][Full Text] [Related]
10. Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.
Trkola A; Ketas TJ; Nagashima KA; Zhao L; Cilliers T; Morris L; Moore JP; Maddon PJ; Olson WC
J Virol; 2001 Jan; 75(2):579-88. PubMed ID: 11134270
[TBL] [Abstract][Full Text] [Related]
11. Dual R3R5 tropism characterizes cerebrospinal fluid HIV-1 isolates from individuals with high cerebrospinal fluid viral load.
Karlsson U; Antonsson L; Ljungberg B; Medstrand P; Esbjörnsson J; Jansson M; Gisslen M
AIDS; 2012 Sep; 26(14):1739-44. PubMed ID: 22695299
[TBL] [Abstract][Full Text] [Related]
12. Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs.
Torre VS; Marozsan AJ; Albright JL; Collins KR; Hartley O; Offord RE; Quiñones-Mateu ME; Arts EJ
J Virol; 2000 May; 74(10):4868-76. PubMed ID: 10775626
[TBL] [Abstract][Full Text] [Related]
13. Pace of Coreceptor Tropism Switch in HIV-1-Infected Individuals after Recent Infection.
Arif MS; Hunter J; Léda AR; Zukurov JPL; Samer S; Camargo M; Galinskas J; Kallás EG; Komninakis SV; Janini LM; Sucupira MC; Diaz RS
J Virol; 2017 Oct; 91(19):. PubMed ID: 28659473
[TBL] [Abstract][Full Text] [Related]
14. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells.
Zhang Y; Lou B; Lal RB; Gettie A; Marx PA; Moore JP
J Virol; 2000 Aug; 74(15):6893-910. PubMed ID: 10888629
[TBL] [Abstract][Full Text] [Related]
15. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
16. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
[TBL] [Abstract][Full Text] [Related]
17. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of CCR5-tropic HIV-1 among treatment-experienced individuals in Spain.
Moreno ; Clotet ; Sarría ; Ortega ; Leal ; Rodriguez-Arrondo ; Sánchez-de la Rosa ;
HIV Clin Trials; 2009; 10(6):394-402. PubMed ID: 20133270
[TBL] [Abstract][Full Text] [Related]
19. Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.
Toma J; Whitcomb JM; Petropoulos CJ; Huang W
AIDS; 2010 Sep; 24(14):2181-6. PubMed ID: 20639728
[TBL] [Abstract][Full Text] [Related]
20. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
